These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7472816)

  • 1. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee.
    Borowitz DS; Grand RJ; Durie PR
    J Pediatr; 1995 Nov; 127(5):681-4. PubMed ID: 7472816
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
    N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosing colonopathy in absence of pancreatic enzyme supplementation in one adult patient with cystic fibrosis.
    Franzen D; Went P; Buhlmann U
    Indian J Gastroenterol; 2008; 27(3):133-4. PubMed ID: 18787288
    [No Abstract]   [Full Text] [Related]  

  • 5. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better".
    Lebenthal E
    J Pediatr Gastroenterol Nutr; 1994 May; 18(4):423-5. PubMed ID: 8071775
    [No Abstract]   [Full Text] [Related]  

  • 6. Is fibrosing colonopathy an immune mediated disease?
    Lee J; Ip W; Durie P
    Arch Dis Child; 1997 Jul; 77(1):66-70. PubMed ID: 9279159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
    Kraisinger M; Hochhaus G; Stecenko A; Bowser E; Hendeles L
    J Clin Pharmacol; 1994 Feb; 34(2):158-66. PubMed ID: 8163716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First adult patient with fibrosing colonopathy.
    Häusler M; Meilicke R; Biesterfeld S; Heimann G
    Am J Gastroenterol; 1998 Jul; 93(7):1171-2. PubMed ID: 9672356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis-associated colitis and fibrosing colonopathy.
    Schwarzenberg SJ; Wielinski CL; Shamieh I; Carpenter BL; Jessurun J; Weisdorf SA; Warwick WJ; Sharp HL
    J Pediatr; 1995 Oct; 127(4):565-70. PubMed ID: 7562277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosing colonopathy in an adult caused by over use of pancreatic enzyme supplements.
    Häusler M; Heimann G; Meilcke R; Biesterfeld S
    Gut; 2000 Oct; 47(4):598. PubMed ID: 11203308
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrosing colonopathy in children with cystic fibrosis.
    Reichard KW; Vinocur CD; Franco M; Crisci KL; Flick JA; Billmire DF; Schidlow DV; Weintraub WH
    J Pediatr Surg; 1997 Feb; 32(2):237-41; discussion 241-2. PubMed ID: 9044129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
    Waters BL
    Pediatr Dev Pathol; 1998; 1(1):74-8. PubMed ID: 10463274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosing colonopathy in children with cystic fibrosis.
    Littlewood JM
    Postgrad Med J; 1996 Mar; 72(845):129-30. PubMed ID: 8731700
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D; Ball LM; Dezfulian AR; Southgate A; Howard CV
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term experience with ZENPEP in infants with exocrine pancreatic insufficiency associated with cystic fibrosis.
    Wooldridge JL; Schaeffer D; Jacobs D; Thieroff-Ekerdt R
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):612-5. PubMed ID: 25050848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing colonopathy in children with cystic fibrosis.
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S11-29. PubMed ID: 8869179
    [No Abstract]   [Full Text] [Related]  

  • 17. What is the current FDA-approved therapy to treat pancreatic insufficiency for children with cystic fibrosis?
    Mennitt D
    NASN Sch Nurse; 2012 Mar; 27(2):67-8. PubMed ID: 22567777
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrosing colonopathy in cystic fibrosis.
    Smyth RL
    Arch Dis Child; 1996 May; 74(5):464-8. PubMed ID: 8669970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of several preparation types of the pancreatic extract Pancrex V in the treatment of cystic fibrosis].
    Braggion C; Mastella G
    Minerva Pediatr; 1985 Nov; 37(21-22):891-6. PubMed ID: 3912659
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
    Littlewood JM; Wolfe SP; Conway SP
    Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.